title: [Ciprofloxacin in the treatment of Legionnaires' disease].
abstract: Case report on a granulocytopenic patient suffering from acute myeloid leukaemia and legionnaire's disease as a complication. Under therapy with ciprofloxacin (2 x 200 mg/die) the symptoms decreased within five days; hence, ciprofloxacin seems to be a good alternative to erythromycin and rifampicin in the therapy of legionnaire's disease in immunodeficient patients.
authors.affiliation: Abteilung für Hämatologie/Onkologie, Städtischen Kliniken Kassel.
authors.forename: L
authors.initials: L
authors.lastname: Zabel
authors.forename: W D
authors.initials: WD
authors.lastname: Hirschmann
mesh_terms: D000907:Antibodies, Bacterial / Q000032:analysis; D002939:Ciprofloxacin / Q000627:therapeutic use*; D006801:Humans; D007875:Legionella / Q000276:immunology; D007877:Legionnaires' Disease / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000907:Antibodies, Bacterial; D002939:Ciprofloxacin
vernacular_title: Ciprofloxacin in der Behandlung der Legionärskrankheit.